Amadeus Ventures will expand into the Asia-Pacific region early next year, roughly six years after being founded by its Spanish parent company.

The neurological disease therapy developer had raised about $57m from investors including Alphabet, Johnson & Johnson and Biogen.

Cancer data platform operator MedBanks raised the capital in a series D-plus round led by Tencent, also a contributor to its series D in January.